CSIMarket



Biogen Inc   (BIIB)
Other Ticker:  
 
 

BIIB's Net Cash Flow Growth by Quarter and Year

Biogen Inc 's Net Cash Flow results by quarter and year




BIIB Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 735.40 -934.60 552.20
III Quarter September - -174.80 -184.20 640.00
II Quarter June - 510.10 -197.60 827.10
I Quarter March -502.70 -80.70 -335.10 1,019.00
FY   -502.70 990.00 -1,651.50 3,038.30



BIIB Net Cash Flow first quarter 2022 Y/Y Growth Comment
Biogen Inc in the first quarter 2022 recorded net cash outflow of $ -502.70 millions.

Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 19 other companies have achieved higher Net Cash Flow growth. While Biogen Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 544 in the first quarter 2022.




BIIB Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -43.95 %
II Quarter June - - - -
I Quarter March - - - -59.8 %
FY   - - - -

Financial Statements
Biogen Inc 's first quarter 2022 Net Cash Flow $ -502.70 millions BIIB's Income Statement
Biogen Inc 's first quarter 2021 Net Cash Flow $ -80.70 millions Quarterly BIIB's Income Statement
New: More BIIB's historic Net Cash Flow Growth >>


BIIB Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -13.72 %
III Quarter September - - - -22.62 %
II Quarter June - - - -18.83 %
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #20
Healthcare Sector #82
Overall #544

Net Cash Flow Y/Y Growth Statistics
High Average Low
803.19 % 71.4 % -96.92 %
(Sep 30 2018)   (Jun 30 2018)
Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #20
Healthcare Sector #82
Overall #544
Net Cash Flow Y/Y Growth Statistics
High Average Low
803.19 % 71.4 % -96.92 %
(Sep 30 2018)   (Jun 30 2018)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Biogen Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's I. Quarter Q/Q Net Cash Flow Comment
Current net cash outflow of -502.70 millions by Biogen Inc appear even worse compare to the 735.40 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Biogen Inc achieved highest sequential Net Cash Flow growth. While Biogen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's I. Quarter Q/Q Net Cash Flow Comment
Recent results of -502.70 millions by Biogen Inc appear even less good compare to the net cash outflow 735.40 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Biogen Inc achieved highest sequential Net Cash Flow growth. While Biogen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Biogen Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Cash Flow 12 Months Ending $ 568.00 $ 990.00 $ -680.00 $ -689.40 $ -1,397.10
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) -42.63 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 544 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Biogen Inc had cumulative twelve months Net Cash Flow of $ 568 millions compare to net cash outflow of $ -1,397 millions a year ago.

Biogen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
803.19 %
71.4 %
-96.92 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
2593.52 %
223.37 %
-86.15 %
(Dec. 30, 2014)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 82
S&P 500 # 544
Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Biogen Inc had cumulative twelve months Net Cash Flow of $ 568 millions compare to net cash outflow of $ -1,397 millions a year ago.

Biogen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
803.19 %
71.4 %
-96.92 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
2593.52 %
223.37 %
-86.15 %
(Dec. 30, 2014)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 82
S&P 500 # 544




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BIIB's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BIIB's Competitors
Net Cash Flow Growth for Biogen Inc 's Suppliers
Net Cash Flow Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2022
Biomx Inc 763.82%$ 763.820 millions
Lftd Partners Inc 662.48%$ 662.485 millions
Viemed Healthcare Inc 624.14%$ 624.138 millions
Intelgenx Technologies Corp 559.80%$ 559.801 millions
Amphastar Pharmaceuticals Inc 531.38%$ 531.382 millions
Vir Biotechnology Inc 452.44%$ 452.442 millions
Adial Pharmaceuticals Inc.435.82%$ 435.820 millions
Fonar Corporation403.91%$ 403.913 millions
Natera Inc 349.75%$ 349.751 millions
Inotiv inc.347.62%$ 347.624 millions
Twist Bioscience Corporation327.39%$ 327.390 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMAR's Profile

Stock Price

AMAR's Financials

Business Description

Fundamentals

Charts & Quotes

AMAR's News

Suppliers

AMAR's Competitors

Customers & Markets

Economic Indicators

AMAR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071